Hanmi Pharm Slides: What Traders Should Monitor in 2026
Hanmi Pharm faces downward pressure amid sector rotation and macro uncertainty. Here's what the data suggests for traders navigating today's move.
Stocks
Stocks Market Insights
Daily analysis of stocks markets, trends, and trading opportunities.
Australia Stocks Higher: ASX 200 August 2026 Analysis
Australia's benchmark index closed higher on August 24, reflecting cautious optimism amid shifting sector rotations and macroeconomic data.
Korean Retail Traders Rally 2026: Data & Risks
After a sharp market correction, Korean retail investors are aggressively re-entering equities. We analyze the data, incentives, and risks shaping this speculative surge.
Is the Fed's Valuation Model Working Again in 2026?
As equity valuations stretch, traders are revisiting the Federal Reserve's valuation model. We examine what it suggests for 2026 positioning.
U.S. Stock Futures Rebound, but 5% Treasury Yields Are the Real Market Risk
U.S. equity futures are rebounding after a difficult session, but Treasury yields remain the bigger story. With the 10-year near 4.7%, the 30-year around 5.25% and oil close to $94, investors face a rapidly changing valuation regime.
SK Hynix’s Tentative Bonus Deal: 60% in Stock, $547K Average
SK Hynix’s preliminary wage deal would pay at least 60% of 2026 bonuses in shares, with the average payout estimated at 779 million won ($547,000).
U.S. Stock Futures Steady as Yields and Oil Press Markets
U.S. equity futures appear steadier this morning as elevated Treasury yields and oil volatility continue to shape near-term market sentiment.
Asian Equities Rise on Tech Momentum, Japan GDP Data Adds Caution
Asian equities gain as China and Hong Kong tech sectors lead, while Japan's GDP miss introduces regional caution.
Anthropic IPO Valuation Tied to $200B 2028 Revenue Target
Reuters reports Anthropic's IPO pricing may hinge on a $200B 2028 revenue projection. Here is what this target suggests for AI equity positioning.